Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
People with HIV had low rates of complications similar to those of HIV-negative patients.
As an eligibility barrier cracks, a lung cancer patient gets a new lease on life.
European and U.S. guidelines recommend that all those with cirrhosis undergo biannual screening for liver cancer.
Could new cancer drugs restore immune responses against HIV?
Keytruda and Imfinzi showed response rates and safety profiles similar to those seen in HIV-negative people.
Nearly 21 million Americans could lose coverage. Meanwhile, the GOP won’t offer a health care replacement until after 2020.
Cancer organizations and the Food and Drug Administration want to broaden eligibility criteria for cancer clinical trials.
Study suggests current lung cancer screening guidelines may be inadequate for HIV-positive people.
Clinical trials often exclude key patient populations, including children and people living with HIV or hepatitis B or C.
People with HIV who have higher viral load and worse immune function appear to be at higher risk for hepatocellular carcinoma.
HIV-positive women had shorter overall survival than HIV-negative women with breast cancer in a study in Botswana.
Cannabis as medicine is back
Treatment with checkpoint inhibitors appears safe and effective for HIV-positive people.
The patient advocacy coalition I Am Essential sent a letter to the HHS spelling out why the plan is dangerous.
HIV, anti-vaxxers, dengue fever and weak primary health care make the World Health Organization’s list of priorities.
A look at the 2019 State of the Union address
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.